Skip to main content

Newsroom press releases

29/01/26 - 7:03

Diasorin has been granted De novo authorization in the U.S. for the First Fully Automated Laboratory Test for Hepatitis Delta Virus (HDV) on the LIAISON XL (128.56 KB)
Products Immunodiagnostic

27/01/26 - 16:05

The Shareholders' meeting authorized the purchase of treasury shares, approved the amendment of art. 5 of the articles of association and authorized the cancellation of treasury shares. The Board approved the launch of the buyback plan. (120.91 KB)
Other

26/01/26 - 7:09

Diasorin signs exclusive distribution agreement for the LIAISON NES® molecular point‑of‑care platform and the Flu A/B, RSV & Covid‑19 panel (131.63 KB)
Products Molecular

23/01/26 - 17:49

Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer. (108.99 KB)
Other

23/12/08 - 1:00

Financial instruments to employees (26.19 KB)
Financial Data

21/11/08 - 1:00

Financial instruments to employees (23.66 KB)
Financial Data

13/11/08 - 1:00

The BoD approves Q3'08 results (171.93 KB)
Financial Data

22/09/08 - 2:00

Agreement in Japan with Advanced Life Science Institute (99.16 KB)
Acquisition / Partnership

08/08/08 - 2:00

The BoD approves H1'08 results (194.3 KB)
Financial Data

09/07/08 - 2:00

Acquisition of Biotrin (99.08 KB)
Acquisition / Partnership

16/05/08 - 2:00

Financial instruments to employees (23.28 KB)
Financial Data

15/05/08 - 2:00

Results for Q1'08 (159.78 KB)
Financial Data

24/04/08 - 2:00

2007 statutory financial Statements approved (93.67 KB)
Financial Data

21/04/08 - 2:00

2008 Financial calendar update (93.56 KB)
Financial Data

19/03/08 - 1:00

The BoD approves FY 2007 results (198.25 KB)
Financial Data

14/02/08 - 1:00

The BoD approves Q4'07 results (170.91 KB)
Financial Data

29/01/08 - 1:00

2008 Financial calendar (88.78 KB)
Financial Data

07/01/08 - 1:00

Financial instruments to employees (29.51 KB)
Financial Data